关注
Puneet Rawat, PhD
Puneet Rawat, PhD
Department of Immunology, Institute of clinical medicine, University of Oslo
在 medisin.uio.no 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies
R Akbar, H Bashour, P Rawat, PA Robert, E Smorodina, TS Cotet, ...
MAbs 14 (1), 2008790, 2022
68*2022
Toward real-world automated antibody design with combinatorial Bayesian optimization
A Khan, AI Cowen-Rivers, A Grosnit, PA Robert, V Greiff, E Smorodina, ...
Cell Reports Methods 3 (1), 2023
44*2023
Protein aggregation: in silico algorithms and applications
R Prabakaran, P Rawat, AM Thangakani, S Kumar, MM Gromiha
Biophysical reviews 13, 71-89, 2021
422021
Unconstrained generation of synthetic antibody–antigen structures to guide machine learning methodology for antibody specificity prediction
PA Robert, R Akbar, R Frank, M Pavlović, M Widrich, I Snapkov, ...
Nature Computational Science 2 (12), 845-865, 2022
332022
ANuPP: a versatile tool to predict aggregation nucleating regions in peptides and proteins
R Prabakaran, P Rawat, S Kumar, MM Gromiha
Journal of Molecular Biology 433 (11), 166707, 2021
312021
CPAD 2.0: a repository of curated experimental data on aggregating proteins and peptides
P Rawat, R Prabakaran, R Sakthivel, A Mary Thangakani, S Kumar, ...
Amyloid 27 (2), 128-133, 2020
292020
Why are ACE2 binding coronavirus strains SARS‐CoV/SARS‐CoV‐2 wild and NL63 mild?
P Rawat, S Jemimah, PK Ponnuswamy, MM Gromiha
Proteins: Structure, Function, and Bioinformatics 89 (4), 389-398, 2021
272021
An in-silico method for identifying aggregation rate enhancer and mitigator mutations in proteins
P Rawat, S Kumar, MM Gromiha
International journal of biological macromolecules 118, 1157-1167, 2018
252018
Exploring the sequence features determining amyloidosis in human antibody light chains
P Rawat, R Prabakaran, S Kumar, MM Gromiha
Scientific Reports 11 (1), 13785, 2021
232021
A novel hybrid SEIQR model incorporating the effect of quarantine and lockdown regulations for COVID-19
R Prabakaran, S Jemimah, P Rawat, D Sharma, MM Gromiha
Scientific reports 11 (1), 24073, 2021
192021
Elucidating important structural features for the binding affinity of spike‐SARS‐CoV‐2 neutralizing antibody complexes
D Sharma, P Rawat, V Janakiraman, MM Gromiha
Proteins: Structure, Function, and Bioinformatics 90 (3), 824-834, 2022
172022
Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies
P Rawat, D Sharma, A Srivastava, V Janakiraman, MM Gromiha
Scientific reports 11 (1), 10220, 2021
152021
AggreRATE-Pred: a mathematical model for the prediction of change in aggregation rate upon point mutation
P Rawat, R Prabakaran, S Kumar, MM Gromiha
Bioinformatics 36 (5), 1439-1444, 2020
152020
Evaluation of in silico tools for the prediction of protein and peptide aggregation on diverse datasets
R Prabakaran, P Rawat, S Kumar, MM Gromiha
Briefings in Bioinformatics 22 (6), bbab240, 2021
102021
AbsoluRATE: An in-silico method to predict the aggregation kinetics of native proteins
P Rawat, R Prabakaran, S Kumar, MM Gromiha
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1869 (9), 140682, 2021
82021
Adaptive immune receptor repertoire analysis
V Mhanna, H Bashour, K Lê Quý, P Barennes, P Rawat, V Greiff, ...
Nature Reviews Methods Primers 4 (1), 6, 2024
62024
Understanding the mutational frequency in SARS-CoV-2 proteome using structural features
P Rawat, D Sharma, M Pandey, R Prabakaran, MM Gromiha
Computers in Biology and Medicine 147, 105708, 2022
62022
Effect of charged mutation on aggregation of a pentapeptide: Insights from molecular dynamics simulations
R Prabakaran, P Rawat, N Yasuo, M Sekijima, S Kumar, MM Gromiha
Proteins: Structure, Function, and Bioinformatics 90 (2), 405-417, 2022
32022
Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation
D Sharma, P Rawat, V Greiff, V Janakiraman, MM Gromiha
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1870 (2), 166959, 2024
22024
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
H Bashour, E Smorodina, M Pariset, J Zhong, R Akbar, M Chernigovskaya, ...
bioRxiv, 2023.10. 26.563958, 2023
2*2023
系统目前无法执行此操作,请稍后再试。
文章 1–20